Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Avalo Therapeutics, Inc. (AVTX)

Autolus Therapeutics PLC Sponsored ADR and Avalo Therapeutics, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Avalo Therapeutics, Inc. are of similar size ($388.8M and $376.6M). Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 193.3% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −238.7%) and the lower return on invested capital (−118.2% vs 0.00%). Across the 18 metrics below, Avalo Therapeutics, Inc. leads on 13 and Autolus Therapeutics PLC Sponsored ADR on 5.

Valuation

Metric AUTL AVTX Biotechnology median
P/E n/m n/m 10.64
P/S 3.22 254.55 9.59
P/B 5.05 0.71 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m 0.78 0.65
EV/Sales 2.15 (57.24) 9.45
Earnings yield (74.65%) (65.26%) (34.69%)
Free cash flow yield (67.18%) (43.84%) (24.02%)

Profitability

Metric AUTL AVTX Biotechnology median
Gross margin 15.66% 64.72% 65.59%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (36.27%) (51.96%)
Return on assets (46.15%) (32.50%) (46.06%)
Return on invested capital 0.00% (118.21%) 0.00%

Growth

Metric AUTL AVTX Biotechnology median
Revenue growth (TTM) 193.29% (92.65%) 4.59%
EPS growth (last fiscal year) (25.58%) 72.07% 29.88%
Revenue growth, 5-year CAGR 113.11% (61.19%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL AVTX Biotechnology median
Debt to equity 1.04 0.00 0.00
Current ratio 4.89 19.31 4.86
Net debt to EBITDA 1.16 1.36 1.01

Dividend

Metric AUTL AVTX Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric AUTL AVTX Biotechnology median
Market cap 376.62m 388.82m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack